OSE Immunotherapeutics S.A.
OSE.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | €37,445 | -€23,003 | -€17,760 | -€16,850 |
| Dep. & Amort. | €6,257 | €3,471 | €3,537 | €2,606 |
| Deferred Tax | €0 | -€223 | -€264 | -€366 |
| Stock-Based Comp. | €0 | €1,746 | €2,728 | €3,773 |
| Change in WC | €1,980 | -€835 | -€3,142 | €1,025 |
| Other Non-Cash | €2,758 | -€920 | -€3,351 | -€107 |
| Operating Cash Flow | €48,440 | -€19,764 | -€18,252 | -€9,919 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -€77 | -€232 | -€274 | -€472 |
| Net Acquisitions | €0 | €0 | €0 | €0 |
| Inv. Purchases | -€46,567 | €0 | €0 | €0 |
| Inv. Sales/Matur. | €0 | €0 | €300 | €0 |
| Other Inv. Act. | -€265 | -€275 | €0 | -€355 |
| Investing Cash Flow | -€46,909 | -€507 | €26 | -€827 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -€3,336 | €7,742 | €11,046 | €15,241 |
| Stock Issued | €1,157 | €11,657 | €6 | €265 |
| Stock Repurch. | €0 | €0 | €0 | €0 |
| Dividends Paid | €0 | €0 | €0 | €0 |
| Other Fin. Act. | -€1,279 | -€6,075 | -€785 | -€549 |
| Financing Cash Flow | -€3,458 | €13,324 | €10,267 | €14,957 |
| Forex Effect | €0 | -€1 | €0 | €0 |
| Net Chg. in Cash | -€1,927 | -€6,948 | -€7,959 | €4,211 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | €18,672 | €25,620 | €33,579 | €29,368 |
| End Cash | €16,745 | €18,672 | €25,620 | €33,579 |
| Free Cash Flow | €48,363 | -€19,996 | -€18,526 | -€10,391 |